Study shows cancer vaccines led to long-term survival for patients with metastatic melanoma

Hoag Memorial Hospital Presbyterian today announced promising data from a clinical study showing patient-specific cancer vaccines derived from patients' own cancer cells and immune cells were well tolerated and resulted in impressive long-term survival rates in patients with metastatic melanoma whose disease had been minimized by other therapies.

Read the whole article on Physorg

More from Physorg